| Oct 22 |
The Second-Best Dow Jones Stock Of 2024 Whipsawed After Earnings Beat
|
| Oct 15 |
Solventum Stock Earns 81 RS Rating
|
| Oct 15 |
Solventum commits to 100% renewable electricity by 2030
|
| Oct 15 |
Solventum to Report Third Quarter 2024 Financial Results and Host Conference Call on November 7, 2024
|
| Oct 14 |
Solventum Announces Commitment to 100% Renewable Electricity by 2030
|
| Oct 10 |
Solventum appoints Ryan Egeland as CMO
|
| Oct 10 |
Solventum Names Surgeon and Diagnostics Pioneer Dr. Ryan Egeland as Chief Medical Officer
|
| Oct 8 |
3M’s healthcare spinoff Solventum earns buy at Stifel on faster turnaround
|
| Sep 12 |
Solventum Shares May Gain on the Launch of Its New V.A.C Therapy
|
| Sep 11 |
Solventum: No Rush To Buy As Post-Spin Execution Will Take Time To Play Out
|
